المؤلفون: Gaspar, Nathalie, Campbell-Hewson, Quentin, Gallego Melcon, Soledad, Locatelli, Franco, Venkatramani, Rajkumar, Hecker-Nolting, Stefanie, Gambart, Marion, Bautista, Francisco José, Thebaud, Estelle, Aerts, Isabelle, Morland, Bruce J., Rossig, C., Canete Nieto, Adela, Longhi, Alessandra, Lervat, Cyril, Entz-Werlé, Natacha, Strauss, Sandra J., Marec-Berard, Perrine, Okpara, Chinyere E., He, Cixin Steven, Dutta, Lea, Casanova, Michela

المساهمون: Centre Régional de Lutte contre le Cancer Oscar Lambret Lille (UNICANCER/Lille), Université de Lille-UNICANCER, Laboratoire de Bioimagerie et Pathologies (LBP), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)

المصدر: ISSN: 2059-7029 ; ESMO Open ; https://hal.science/hal-03879123Test ; ESMO Open, 2021, 6 (5), pp.100250. ⟨10.1016/j.esmoop.2021.100250⟩.

مصطلحات موضوعية: lenvatinib osteosarcoma pediatric solid tumors tyrosine kinase inhibitors, lenvatinib, osteosarcoma, pediatric, solid tumors, tyrosine kinase inhibitors, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology

العلاقة: hal-03879123; https://hal.science/hal-03879123Test; https://hal.science/hal-03879123/documentTest; https://hal.science/hal-03879123/file/1-s2.0-S2059702921002118-main.pdfTest

الإتاحة: https://doi.org/10.1016/j.esmoop.2021.100250Test
https://hal.science/hal-03879123Test
https://hal.science/hal-03879123/documentTest
https://hal.science/hal-03879123/file/1-s2.0-S2059702921002118-main.pdfTest

المؤلفون: Motzer, Robert, Porta, Camillo, Alekseev, Boris, Rha, Sun Young, Choueiri, Toni K, Mendez-Vidal, Maria Jose, Hong, Sung-Hoo, Kapoor, Anil, Goh, Jeffrey C, Eto, Masatoshi, Bennett, Lee, Wang, Jinyi, Pan, Jie Janice, Saretsky, Todd L, Perini, Rodolfo F, He, Cixin Steven, Mody, Kalgi, Cella, David

المساهمون: Motzer, Robert, Porta, Camillo, Alekseev, Bori, Rha, Sun Young, Choueiri, Toni K, Mendez-Vidal, Maria Jose, Hong, Sung-Hoo, Kapoor, Anil, Goh, Jeffrey C, Eto, Masatoshi, Bennett, Lee, Wang, Jinyi, Pan, Jie Janice, Saretsky, Todd L, Perini, Rodolfo F, He, Cixin Steven, Mody, Kalgi, Cella, David

مصطلحات موضوعية: CLEAR study, lenvatinib, pembrolizumab, sunitinib, progression-free survival, overall survival, advanced renal cell carcinoma

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35489363; info:eu-repo/semantics/altIdentifier/wos/WOS:000831830800022; volume:23; issue:6; firstpage:768; lastpage:780; numberofpages:13; journal:THE LANCET ONCOLOGY; https://hdl.handle.net/11586/464740Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85131115613

الإتاحة: https://doi.org/10.1016/s1470-2045Test(22)00212-1
https://hdl.handle.net/11586/464740Test